Novel Drug May Help Repair Failing Hearts
Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure, according to a first-in-man study published today in JACC: Basic to Translational Science.
Heart failure, characterized by a loss of cardiac function, is among the leading causes of death worldwide. A significant portion of heart failure patients, particularly those with severe left ventricular systolic dysfunction, do not sufficiently respond to current medical therapy.
Researchers examined the safety and efficacy of a single infusion of cimaglermin, which acts as a growth factor for the heart, helping the structural, metabolic and contractile elements of the heart to repair itself following injury. The study enrolled 40 heart failure patients who were taking optimal medical therapy for at least three months prior to the trial. Compared to patients who received a placebo, patients who received a high dose of cimaglermin had a sustained increase in left ventricular ejection fraction, or pumping capacity, through 90 days after dosing, with the maximum increase reached at day 28.
“These findings support continued clinical development of the investigational drug cimaglermin, including further safety evaluations and detailing the potential improvement on clinical heart failure outcome measures,” said Daniel J. Lenihan MD, from the division of cardiovascular medicine at Vanderbilt University and the lead author of the study. “As with all experimental therapeutics, additional studies will be required and subject to regulatory review to determine if the relative risks and benefits of cimaglermin warrant approval.”
The most common side effects were headache and nausea, which were temporarily associated with exposure to the drug. One patient receiving the highest planned dose of cimaglermin experienced an adverse reaction that met the stopping criteria of Federal Drug Administration guidance for drug induced liver injury.
Limitations of this study include the small sample size and the fact that patients only received a single infusion rather than multiple doses.
“Although the results of the study must be regarded as provisional because of the small numbers of patients, the results of this study are nonetheless very exciting,” said Douglas L. Mann, MD, FACC, editor-in-chief of JACC: Basic to Translational Science. “Instead of blocking the fundamental mechanisms that lead to cardiac injury, the early results with cimaglermin suggest that it may also be possible to administer therapeutics that allow the failing heart to repair itself using its own repair mechanisms. If the results of this study can be replicated and translated into improvements in clinical outcomes in larger numbers of patients in phase II and III clinical trials, it will represent a paradigm shift in the way in which clinicians treat patients with heart failure.”
Learn more: Novel Drug May Help Repair Failing Hearts
Receive an email update when we add a new HEART FAILURE article.
The Latest on: Restore cardiac function
via Google News
The Latest on: Restore cardiac function
- Scientists uncover new genetic mutations linked to autism spectrum disorderon June 24, 2020 at 9:01 am
The study is the first to link neurodevelopmental delays with CNOT1, suggesting that drugs that help restore the ... unknown genetic link between heart function and ASD." Developmental ...
- Affluent Medical Announces €15.8 Million in New Financing and Strengthening of Its Board of Directorson June 24, 2020 at 7:09 am
Affluent Medical is a French MedTech company specialized in innovative, minimally-invasive implants designed to restore key physiological functions in ...
- Affluent Medical Announces the Launch of the MINERVA First-In-Human Clinical Study of EPYGONon June 24, 2020 at 6:57 am
Affluent Medical is a French MedTech company specialized in innovative, minimally-invasive implants designed to restore key physiological functions in patients suffering from structural heart diseases ...
- Insight into merits and limitations of direct reprogramming strategies for cardiac regenerationon June 22, 2020 at 4:13 pm
Today, only a handful of cell therapy-based strategies that include induced pluripotent stem cells, embryonic stem cells, bone marrow, liposuction, heart biopsies are known to restore the function of ...
- The Connection Between Heart Attack and Sudden Cardiac Arrest and How ZOLL LifeVest Can Helpon June 17, 2020 at 11:22 am
The Connection Between Heart Attack and Sudden Cardiac Arrest and How ZOLL LifeVest Can Help For the hundreds of thousands of people who experience a ...
- Here's what's happening with the Lear Theater's redevelopment, writes Artown directoron June 11, 2020 at 5:35 pm
Ken Krater, President of Krater Consulting Group, and his team are working on plans to restore the Lear Theater in the heart of the Powning ... Lear Theater needs to function as our local ...
- Link between liver and heart disease could lead to new therapeuticson June 10, 2020 at 7:20 am
A new study that looks closely at the cardiac health of flies provides new evidence that liver dysfunction may lead to deterioration of the heart. But Bai said no direct link between liver and ...
- Elder Scrolls Online Greymoor PS4 2.04 Update Patch Notes Releasedon June 10, 2020 at 2:59 am
In this patch, you can travel to the Nord nation of Western Skyrim and uncover the Dark Heart of Skyrim ... You and your allies restore 2358 Health every 1 second while inside the circle.
- Let’s Talk About Arrhythmiason June 5, 2020 at 12:22 pm
They all function without any input from you (imagine ... occurs. It shocks the heart to restore a normal heartbeat. What Are the Best Lifestyle Changes for Arrhythmias? In addition to sticking ...
via Bing News